Publication

Canagliflozin and Renal Outcomes in Diabetic Nephropathy

Post, A., Eisenga, M. F. & Bakker, S. J. L., 12-Sep-2019, In : New England Journal of Medicine. 381, 11, p. 1089 1 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Copy link to clipboard

Documents

  • Canagliflozin and Renal Outcomes in Diabetic Nephropathy

    Final publisher's version, 242 KB, PDF document

    Embargo ends: 12/03/2020

    Request copy

DOI

Original languageEnglish
Pages (from-to)1089
Number of pages1
JournalNew England Journal of Medicine
Volume381
Issue number11
Publication statusPublished - 12-Sep-2019

    Keywords

  • Canagliflozin, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Kidney, Sodium-Glucose Transporter 2 Inhibitors

View graph of relations

ID: 97113711